European cystic fibrosis society share their registry experience
The European Cystic Fibrosis Society Patient Registry (ECFSPR) is one of OpenApp's more mature registries having first been developed in 2012. It has grown exponentially through the continued work of both the European Cystic Fibrosis Society (ECFS) and OpenApp and currently accommodates 56,000 patients across 39 countries in 2022.
We are looking back at a 2019 presentation given by ECFS titled, "ECFS Patient Registry". Presented by Jacqui Van Rens (Executive Registry Coordinator), this talk is an excellent resource for those new to the patient registry space to gain a footing in what a registry is and the potential they hold for rare disease patient organisations today.
In the presentation Jacqui outlines many of the motivating factors for ECFS setting up a registry, which in OpenApp's experience, mirror those of many patient organisations today:
- The ability to collect data to describe the natural history of the condition.
- Collate information on the effectiveness and safety of treatments employed.
- A tool to empower stakeholders to drive the improvement of care.
The needs of ECFS are dynamic and constantly evolving so it is paramount that they have a system with the flexibility to address them: whether that be allowing for expansion through new countries/centres, providing clinicians multiple avenues for data capture (whether it be once a year or at each patient visit), or supporting pharmacovigilance needs for new medications.
For those organisations who want their registry to encompass many different countries/centres, ECFS is an appropriate example of how international registries can work. Countries can even benchmark performance of their respective centres against others to see if improvements in care are required, this type of breakdown informs the annual public facing reports that ECFS share with it’s community.
Through the platform ECFS has been able to engage industry with anonymized real world data informing phase 2 and phase 3 clinical trials, and in 2020 enrolled 603 CF patients to clinical trials.
Head to the CF Trust website to watch the presentation by Jacqui Van Rens about the ECFS Patient Registry. To learn more about the ECFS Patient Registry, please head to the ECFS website.
To discuss with OpenApp how we can help you on your registry journey, please contact us.
Real-World Data Collection Enables Evaluating the Safety and Effectiveness of Treatments for Spinal Muscular Atrophy
This exciting initiative combines collecting real-world patient data by neurologists, clinicians and patients to enable clinical research and engagement of spinal muscular atrophy patients receiving treatment.
SMArtCARE is a multi-year joint initiative of neurologists, paediatricians, and patients with spinal muscular atrophy (SMA). Spinal muscular atrophy refers to a group of rare genetic diseases resulting in muscle wastage and weakness. Symptom onset can be seen in both children and adults but the most severe form typically presents in children under 18 months old. Until recent treatments survival past childhood was unusual.Read More
The NF registry is a one of a kind project, where the OpenApp team worked in collaboration with CTF to develop and support a platform that meets their requirements, as a secure and effective tool to empower NF patients and their caregivers. A dedicated registry is the most efficient way to raise awareness/advocate for NF, expand the NF community, and connect to help end NF.Read More
Combining the development efforts and the ongoing maintenance of your software is key to ensuring that you have a robust and constantly improving and evolving solution.
Having a software maintenance plan is just as important as the initial development. Professionally managed maintenance allows for the continual improvement and adaptation to changing business needs and technological advancements.Read More